Clinical Trials

A Phase 1, Open-Label, Dose Escalation, Safety, and Tolerability Study of INCB054828 in Subjects with Advanced Malignancies


Study ID
Incyte INCB 54828-101

NCT Number
NCT02393248 (Click on the NCT number for more information about the trial)

Research Study Number
00005749

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
Incyte


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now